changes in the treatment of Parkinson's

May 1998

You'll see changes in the treatment of Parkinson's. There aremore options now with the new drugs on the market.

Levodopa (Sinemet, etc) is still the most effective. But afterseveral years, it starts to lose its effect and may cause dyskinesias.There's some concern that levodopa might be neurotoxic.

That's why there's so much interest in "levodopa-sparing" drugs.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

RECOMMENDING vitamin and mineral supplements
tamoxifen to PREVENT breast cancer
Diabetes Prandin (repaglinide), a new oral hypoglycemic for type 2 diabetes
Cholesterol Tricor (fenofibrate) for patients with high triglycerides (TGs)
Cholesterol Niaspan, a new sustained-release niacin
Cholesterol Pravachol (pravastatin) and Zocor (simvastatin) are now approved to prevent STROKE
Lice unusual head lice treatments
Renal & Urology Detrol (tolterodine) for urinary frequency, urgency, or urge incontinence
Renal & Urology DDAVP (desmopressin) TABLETS for bed-wetting
Gastroenterology omeprazole (Prilosec) to prevent and treat NSAID-induced ulcers
Parkinson's Disease changes in the treatment of Parkinson's
Cardiology whether patients with heart failure should get warfarin
Ophthalmology two new eye drops for glaucoma
Ophthalmology several new prescription eye drops for allergies and inflammation
adverse drug reactions

changes in the treatment of Parkinson's

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents